{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:31:59Z","timestamp":1786635119280,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Indian Acad Neurol"],"published-print":{"date-parts":[[2008]]},"DOI":"10.4103\/0972-2327.42932","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T06:41:56Z","timestamp":1235025716000},"page":"140","source":"Crossref","is-referenced-by-count":3,"title":["Autoantibodies in neuromuscular transmission disorders"],"prefix":"10.4103","volume":"11","author":[{"given":"Angela","family":"Vincent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0972-2327.42932-1","first-page":"89","volume-title":"Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor","author":"Tzartos","year":"1998","journal-title":"Immunol Rev"},{"key":"key-10.4103\/0972-2327.42932-2","doi-asserted-by":"crossref","unstructured":"Toyka KV, Drachman DB, Griffin DE, Pestronk A, Winkelstein JA, Fishbeck KH, Kao I. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med 1977;296:125-31.","DOI":"10.1056\/NEJM197701202960301"},{"key":"key-10.4103\/0972-2327.42932-3","first-page":"266","volume-title":"Function of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigation by plasma exchange","author":"Newsom-Davis","year":"1978","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.42932-4","first-page":"797","volume-title":"Unravelling the pathogenesis of myasthenia gravis","author":"Vincent","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"key-10.4103\/0972-2327.42932-5","first-page":"2843","volume-title":"Myasthenia gravis: Past, present, and future","author":"Conti-Fine","year":"2006","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0972-2327.42932-6","first-page":"1797","volume-title":"Myasthenia gravis","author":"Drachman","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0972-2327.42932-7","first-page":"99","volume-title":"Seronegative generalised myasthenia gravis: Clinical features, antibodies and their targets","author":"Vincent","year":"2003","journal-title":"Lancet Neurol"},{"key":"key-10.4103\/0972-2327.42932-8","first-page":"1105","volume-title":"Evidence of underdiagnosis of myasthenia gravis in older people","author":"Vincent","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0972-2327.42932-9","first-page":"332","volume-title":"Teratogen update: Maternal myasthenia gravis as a cause of congenital arthrogryposis","author":"Polizzi","year":"2000","journal-title":"Teratology"},{"key":"key-10.4103\/0972-2327.42932-10","first-page":"442","volume-title":"Striational antibodies in myasthenia gravis: reactivity and possible clinical significance","author":"Romi","year":"2005","journal-title":"Arch Neurol"},{"key":"key-10.4103\/0972-2327.42932-11","first-page":"163","volume-title":"Autoimmunizing mechanisms in thymoma and thymus","author":"Willcox","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/0972-2327.42932-12","first-page":"893","volume-title":"Myasthenia gravis thymus: Complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status","author":"Leite","year":"2007","journal-title":"Am J Pathol"},{"key":"key-10.4103\/0972-2327.42932-13","first-page":"365","volume-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"key-10.4103\/0972-2327.42932-14","first-page":"580","volume-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0972-2327.42932-15","first-page":"756","volume-title":"Paraneoplastic diseases associated with thymoma","author":"Evoli","year":"2007","journal-title":"J Neurol"},{"key":"key-10.4103\/0972-2327.42932-16","first-page":"1978","volume-title":"Clinical aspects of MuSK antibody positive seronegative MG","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.42932-17","first-page":"84","volume-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","author":"Vincent","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/0972-2327.42932-18","first-page":"568","volume-title":"Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis","author":"Farrugia","year":"2006","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0972-2327.42932-19","first-page":"1481","volume-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","author":"Farrugia","year":"2006","journal-title":"Brain"},{"key":"key-10.4103\/0972-2327.42932-20","first-page":"536","volume-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","author":"Lauriola","year":"2005","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.42932-21","first-page":"444","volume-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","author":"Leite","year":"2005","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0972-2327.42932-22","first-page":"1682","volume-title":"AChR phosphorylation and indirect inhibition of AChR function in seronegative MG","author":"Plested","year":"2002","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.42932-23","first-page":"149","volume-title":"Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation","author":"Spreadbury","year":"2005","journal-title":"J Neuroimmunol"},{"key":"key-10.4103\/0972-2327.42932-24","doi-asserted-by":"crossref","unstructured":"Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, et al. IgG1 antibodies to acetylcholine receptors in \u2032seronegative\u2032 myasthenia gravis. Brain 2008 [Epub ahead of print].","DOI":"10.1093\/brain\/awn092"},{"key":"key-10.4103\/0972-2327.42932-25","first-page":"149","volume-title":"Lambert-Eaton myasthenic syndrome","author":"Mareska","year":"2004","journal-title":"Semin Neurol"},{"key":"key-10.4103\/0972-2327.42932-26","first-page":"678","volume-title":"Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome","author":"Bain","year":"1996","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.42932-27","first-page":"737","volume-title":"Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line","author":"Roberts","year":"1985","journal-title":"Nature"},{"key":"key-10.4103\/0972-2327.42932-28","first-page":"764","volume-title":"P\/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer","author":"Graus","year":"2002","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.42932-29","first-page":"85","volume-title":"An improved diagnostic assay for Lambert-Eaton myasthenic syndrome","author":"Motomura","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0972-2327.42932-30","first-page":"596","volume-title":"The role of autoantibodies in Lambert-Eaton myasthenic syndrome","author":"Lang","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/0972-2327.42932-31","first-page":"1887","volume-title":"Phenotypic variants of autoimmune peripheral nerve hyperexcitability","author":"Hart","year":"2002","journal-title":"Brain"},{"key":"key-10.4103\/0972-2327.42932-32","first-page":"75","volume-title":"Autoimmune aetiology for acquired neuromyotonia (Isaacs\u2032 syndrome)","author":"Sinha","year":"1991","journal-title":"Lancet"},{"key":"key-10.4103\/0972-2327.42932-33","first-page":"238","volume-title":"Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia","author":"Hart","year":"1997","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0972-2327.42932-34","first-page":"2417","volume-title":"Morvan\u2032s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels","author":"Liguori","year":"2001","journal-title":"Brain"},{"key":"key-10.4103\/0972-2327.42932-35","first-page":"123","volume-title":"Autoimmune channelopathies and related neurological disorders","author":"Vincent","year":"2006","journal-title":"Neuron"},{"key":"key-10.4103\/0972-2327.42932-36","first-page":"701","volume-title":"Potassium channel antibody-associated encephalopathy: A potentially immunotherapy-responsive form of limbic encephalitis","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"key-10.4103\/0972-2327.42932-37","first-page":"1177","volume-title":"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody","author":"Thieben","year":"2004","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.42932-38","first-page":"1883","volume-title":"Clinical spectrum of voltage-gated potassium channel autoimmunity","author":"Tan","year":"2008","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.42932-39","first-page":"73","volume-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","author":"Buckley","year":"2001","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0972-2327.42932-40","first-page":"1730","volume-title":"Serum antibodies in epilepsy and seizure-associated disorders","author":"McKnight","year":"2005","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.42932-41","first-page":"135","volume-title":"Antibodies to voltage-gated potassium and calcium channels in epilepsy","author":"Majoie","year":"2006","journal-title":"Epilepsy Res"},{"key":"key-10.4103\/0972-2327.42932-42","doi-asserted-by":"crossref","unstructured":"Irani SR, Buckley C, Vincent A, Cockerell C, Rudge P, Johnson MR, et al. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 2008 in press.","DOI":"10.1212\/01.wnl.0000326572.93762.51"},{"key":"key-10.4103\/0972-2327.42932-43","first-page":"25","volume-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0972-2327.42932-44","doi-asserted-by":"crossref","unstructured":"Hutchinson M, Waters P, McHugh J, Gorman G, O\u2032Riordan S, Connolly S, et al. Progressive encephalomyelitis, rigidity and myoclonus: A novel glycine receptor antibody. Neurology 2008; in press.","DOI":"10.1212\/01.wnl.0000327606.50322.f0"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:42:04Z","timestamp":1786632124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0972-2327.42932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"alternative-id":["42932"],"URL":"https:\/\/doi.org\/10.4103\/0972-2327.42932","relation":{},"ISSN":["0972-2327"],"issn-type":[{"value":"0972-2327","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}